Anesthetic Considerations for Laparoscopic Cholecystectomy with EF 25-30% (Severely Reduced LV Function)

Why EF 25-30% Matters in Laparoscopic Surgery

Preoperative Assessment & Optimization

1. Cardiology consultation and optimization of HF medications is mandatory. The patient should be in the best possible functional state before elective surgery.
2. Echocardiography - confirm EF, assess for diastolic dysfunction, wall motion abnormalities, RV function, valve disease, and pulmonary pressures. Elevated PVR + RV dysfunction adds further risk.
3. GDMT (Goal-Directed Medical Therapy) - ensure ACE inhibitor/ARB, beta-blocker, MRA/SGLT2i are optimized. Hold/continue perioperatively per cardiology guidance.
4. Functional status - estimate MET capacity. <4 METs = high perioperative risk.
5. Risk stratification - use Lee's RCRI or ACS-NSQIP calculator. EF <35% is an independent predictor of 30-day MACE.
6. Renal function - often impaired in reduced EF; guide fluid strategy and drug dosing.
7. Electrolytes (especially K+, Mg2+) - critical to prevent arrhythmias with diuretic use.
8. Consider invasive preoperative monitoring planning (arterial line, central line, TEE availability).

Consider laparoscopic vs. open debate: In EF 25-30%, some centers prefer open cholecystectomy to avoid pneumoperitoneum-induced hemodynamic instability, especially if elective. However, laparoscopic approach still offers advantages (less wall stress, smaller fluid shifts, earlier recovery) if hemodynamics can be closely managed.

Intraoperative Anesthetic Management

1. Monitoring (Enhanced)

• Intra-arterial line (radial artery) - mandatory; continuous beat-to-beat BP monitoring is essential given hemodynamic lability
• Central venous catheter - guides fluid management and vasopressor/inotrope delivery
• Transesophageal Echocardiography (TEE) - gold standard for real-time LV function monitoring, volume status, and detecting new wall motion abnormalities in high-risk cardiac patients
• Cardiac output monitoring (PICCO, PAC in selected cases) - if facilities allow
• Standard ASA monitors + SpO2 + ETCO2

2. Induction Strategy

• Avoid hypotension at induction - the dilated, failing LV is exquisitely sensitive to reductions in SVR and preload
• Etomidate is preferred induction agent - minimal myocardial depression, maintains SVR
• Alternatively, ketamine (maintains sympathetic tone) with caution in tachycardia
• Avoid high-dose propofol as a bolus - causes vasodilation and significant hypotension in low EF patients
• Opioid pre-treatment (fentanyl/remifentanil) to blunt laryngoscopy response - catecholamine surge is dangerous with EF 25-30%
• Slow, titrated induction is key

3. Maintenance

• Volatile anesthetics (sevoflurane/desflurane) - provide some preconditioning benefit; easily titratable
• TIVA with propofol is an alternative (reduces PONV), but titrate carefully to avoid vasodilation
• Remifentanil infusion is highly beneficial - suppresses sympathetic stress response during pneumoperitoneum without prolonged respiratory effects (Barash p. 3622)
• Avoid N₂O - potential for PONV (already a concern), bowel distension, and the risk is not justified
• Dexmedetomidine infusion can reduce sympathetic activation and opioid requirements

4. Pneumoperitoneum Management - KEY CONSIDERATIONS

• Keep IAP ≤ 12 mmHg (not the standard 15 mmHg). Lower IAP reduces SVR elevation and IVC compression.
• Gradual, slow insufflation to allow hemodynamic monitoring and early detection of compromise
• Surgeons must be willing to abort laparoscopic approach and convert to open if hemodynamics deteriorate
• When initiating pneumoperitoneum in supine position, expect: ↑SVR, ↓EF, ↓CI - have vasodilators and inotropes immediately available
• Trendelenburg positioning (reverse for cholecystectomy = head-up) will reduce preload further - be prepared with vasopressors

5. Hemodynamic Targets

• Maintain heart rate 60-80 bpm - tachycardia dramatically increases myocardial oxygen demand in dilated cardiomyopathy
• Maintain MAP adequate for coronary perfusion (typically ≥65 mmHg), but avoid hypertension (↑ afterload)
• Vasopressors of choice: Norepinephrine (maintains SVR without excessive tachycardia); avoid phenylephrine (pure alpha agonism → reflex bradycardia + increases afterload significantly)
• Inotropic support: Dobutamine or milrinone if low output state develops. Milrinone (PDE-3 inhibitor) reduces preload + afterload while improving contractility - well-suited for EF 25-30%
• Fluid strategy: Avoid overloading (risk of acute pulmonary edema) - but maintain adequate preload. TEE-guided fluid administration is ideal.

6. Ventilation

• EF 25-30% patients may have pulmonary venous congestion and reduced lung compliance at baseline
• Lung-protective ventilation: tidal volumes 6-8 mL/kg IBW, PEEP 5-8 cmH₂O
• Monitor closely for ↑ airway pressures when pneumoperitoneum established
• ETCO2 may underestimate PaCO₂ if low cardiac output reduces pulmonary perfusion - consider arterial blood gas sampling
• Hypercarbia from CO₂ absorption → pulmonary vasoconstriction → can strain RV if RV function is compromised

7. Neuromuscular Blockade

• Adequate NMB (deep or moderate) improves surgical working conditions and allows lower IAP settings, which is beneficial in this patient
• Consider sugammadex for reversal (rapid, complete reversal of rocuronium) to avoid neostigmine-induced bradycardia in a compromised heart

8. Analgesia (Multimodal - Opioid-Sparing)

• Wound infiltration + intraperitoneal local anesthetic (bupivacaine/ropivacaine) - reduces postoperative pain and opioid requirement (Barash p. 3622)
• Paracetamol (acetaminophen) - safe in heart failure (provided liver function intact)
• NSAIDs - use with caution/avoid: cause sodium and water retention, can precipitate acute decompensation in HF
• Lidocaine infusion - associated with faster GI recovery and early pain reduction post-laparoscopy
• TAP block (transversus abdominis plane block) for port-site analgesia

Postoperative Considerations

• ICU/HDU monitoring postoperatively - mandatory given EF 25-30%
• Continue invasive arterial monitoring into PACU/ICU
• Avoid fluid overload - the poorly compliant, dilated LV cannot handle excess volume
• Restart HF medications early (especially beta-blockers, ACE-i) - abrupt cessation increases risk of decompensation
• Watch for arrhythmias - electrolyte derangements + catecholamine surge + surgical stress can precipitate AF, VT
• PONV prophylaxis is important - retching/vomiting dramatically increases myocardial oxygen demand; use dual/triple antiemetic regimen (ondansetron + dexamethasone + scopolamine)
• Early mobilization to prevent DVT (these patients often have stasis in dilated ventricle with thrombus risk)
• Ensure adequate oxygenation post-extubation

Special Concerns Unique to EF 25-30%

Summary Table

• Barash Clinical Anesthesia, 9e - Ch. 44 (Laparoscopic Surgery), pp. 3800-3820
• Miller's Anesthesia, 10e - Cardiopulmonary Effects, p. 9857